Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)

Podobne knjige/članki

• Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
  od: Isbel Nicole M, et al.
  Izdano: (2009-07-01)
• Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients
  od: Mudge, David W, et al.
  Izdano: (2009)
• The impact of automated eGFR reporting and education on nephrology service referrals
  od: Noble, Euan, et al.
  Izdano: (2008)
• Life-threatening adenovirus infection in a kidney transplant recipient
  od: Barraclough, Katherine, et al.
  Izdano: (2009)
• Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?
  od: Mudge, David W, et al.
  Izdano: (2011)